James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 6,370 shares at $41.23 ($263K) on 2025-03-21, disclosed to the SEC on 2025-03-24.
Seasonal sale ($263k) by General Counsel and Secretary — this insider has traded CRSP in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.23 | 3,185 | $131K | 50.0% |
| 2 | $41.23 | 3,185 | $131K | 50.0% |
| Total | $41.23 avg | 6,370 | $263K | 100% |
| Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |
| CRSP | SELL | 2026-02-20 | $111K | — | Filing → |